Plains Venture PartnersPlains Venture PartnersPlains Venture PartnersPlains Venture Partners
  • About
  • Portfolio
  • Team
  • Investor Login

Progentec gets i2E funding

    Home News Progentec gets i2E funding
    NextPrevious

    Progentec gets i2E funding

    By sarah | News | 0 comment | 8 November, 2018 | 0

     

    By Journal Record Staff
    Courtesy of the Journal Record

    OKLAHOMA CITY – Progentec Diagnostics Inc. has completion a second round of funding led by i2E, along with Chicago-based OCA Ventures and NMC Lifesciences, a health care provider.

    The funding will help bring Oklahoma City-based Progentec’s tool for identifying lupus flare-ups and a biomarker-based disease-activity index closer to commercialization. Technology created by the Oklahoma Medical Research Foundation is at the core of the platform being developed by Progentec.

    Progentec also announced the acquisition of LupusCorner, a patient-empowerment platform for people with systemic lupus erythematosus and lupus nephritis. By integrating LupusCorner’s technology platform and data insights, Progentec plans to develop a lupus-management platform. The founders of LupusCorner, Arif Sorathia and Brett Adelman, have joined Progentec.

    Progentec’s technologies include bio-marker based tests to diagnose disease before symptoms begin to show, as well as tests to monitor and predict disease activity levels in Lupus.

    “We’ve made tremendous progress in developing a tool for the identification of lupus flare-ups before they occur,” said Mohan Purushothaman, CEO of Progentec. “Today’s funding round is the next step on our journey to making this and other advanced tools commercially available to patients with lupus, a disease that afflicts more than one million Americans, many of whom are women.”

    LupusCorner was founded in 2016.

    Read the article at the Journal Record website

     

     

     

     

    Progentec Diagnostics, The Journal Record

    Related Post

    • Norman’s IMMY has global impact, despite humble beginnings

      By sarah | 0 comment

      By Scott Meacham Copyright © 2019 The Oklahoman Sean and Scott Bauman, CEO and chief operating officer of biotechnology company IMMY, literally grew up in the family business. “There isn’t a job that my brotherRead more

    • Oklahoma’s bioscience prowess busy making a difference worldwide

      By sarah | 0 comment

      By Kevan Goff-ParkerCopyright © 2019 The Oklahoman Greater Oklahoma City Chamber Manager of Innovation and Entrepreneurship Evan Fay said he believes some people may be caught off-guard by Oklahoma’s growing bioscience prowess. He made hisRead more

    • Ascend BioVentures helps determine right path for health care discoveries

      By sarah | 0 comment

      By Scott Meacham Copyright © 2019, The Oklahoman It’s really difficult to invent new drug therapies. Research and development can take decades. Once a potential drug appears viable, testing for safety and efficacy adds moreRead more

    • OSU delegates share future bioscience innovations with leaders

      By sarah | 0 comment

      By Kevan Goff-Parker Copyright © 2019, The Oklahoman PHILADELPHIA — Three Oklahoma State University researchers this week have been connecting face-to-face with some of the world’s top bioscience companies during the 2019 BIO International ConventionRead more

    • Delegation Sharing Oklahoma’s Good News Bioscience Story at BIO International Convention

      By sarah | 0 comment

      By Kevan Goff-Parker Copyright ©2019, The Oklahoman PHILADELPHIA — More than 40 Oklahoma bioscience and industry experts from a wide array of fields are busy telling global industry leaders about the state’s successes in theRead more

    Leave a Comment

    Cancel reply

    You must be logged in to post a comment.

    NextPrevious

    Investor Login

    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Click HERE for directions.

    Tulsa Location

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592

    Click HERE for directions.

    • Disclaimer & Disclosure
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    • Investor Login
    Plains Venture Partners